HealthBridge Releases Comprehensive Analysis of the CY 2026 CMS Home Health PPS Final Rule

HealthBridge announces the release of its comprehensive analysis of the CY 2026 CMS Home Health PPS Final Rule, outlining key payment cuts, PDGM updates, HHVBP changes, and compliance guidance for home health agencies.

PRESS RELEASES

12/6/20255 min read

FOR IMMEDIATE RELEASE

HealthBridge Releases Comprehensive Analysis of the CY 2026 CMS Home Health PPS Final Rule, Highlighting Key Payment, Quality, and Regulatory Changes for Home Health Agencies

Los Angeles, CA — December 2, 2025 — HealthBridge, a leading healthcare compliance, quality assurance, and operational consulting organization, has released its comprehensive analysis of the Centers for Medicare & Medicaid Services (CMS) Calendar Year (CY) 2026 Home Health Prospective Payment System (PPS) Final Rule. The analysis outlines significant regulatory, reimbursement, and quality reporting changes that will directly impact Medicare-certified Home Health Agencies (HHAs) beginning January 1, 2026.

The CY 2026 Final Rule represents a continuation of CMS’s ongoing efforts to refine the Patient-Driven Groupings Model (PDGM), enhance program integrity oversight, and advance value-based purchasing initiatives while maintaining long-term sustainability within the Medicare Home Health benefit.

Although CMS initially proposed a substantially larger payment reduction, the Final Rule establishes a reduced net decrease of approximately $19 per 30-day period. CMS attributes this adjustment to updated utilization data and recalibrated behavioral assumptions under PDGM based on more recent claims experience.

Overall, CMS projects a –1.3% reduction in aggregate Medicare home health payments, equating to approximately $220 million in decreased expenditures for CY 2026.

HealthBridge’s analysis emphasizes that while the financial reduction is smaller than originally anticipated, the combined impact of payment adjustments, quality reporting changes, and compliance expansions will require agencies to reassess operational strategies, clinical documentation practices, and financial forecasting models.

Key Provisions in the CY 2026 Final Rule

Payment Adjustments and PDGM Refinements

A central feature of the CY 2026 Final Rule is the continued refinement of PDGM-based reimbursement methodologies. CMS finalized multiple adjustments designed to align payment accuracy with patient clinical characteristics and utilization trends.

Key payment provisions include:

  • A –1.023% permanent behavioral adjustment, reflecting CMS’s continued recalibration of assumed coding and documentation behaviors under PDGM.

  • A –3.0% temporary adjustment applied for CY 2026, intended to account for historical overpayments associated with behavioral changes observed since PDGM implementation.

  • Updates to case-mix weights, including revisions to comorbidity subgroups, functional impairment categories, and clinical grouping logic.

  • Modifications to Low Utilization Payment Adjustment (LUPA) thresholds, affecting episodes with limited visits.

HealthBridge notes that these updates will not affect all agencies uniformly. Agencies with higher clinical complexity, stronger documentation practices, and optimized coding accuracy may experience different financial impacts than agencies with lower acuity populations or inconsistent documentation workflows.

In addition, CMS continues to emphasize the importance of accurate OASIS data collection, as patient classification under PDGM is heavily dependent on clinical and functional assessment data.

Home Health Quality Reporting Program (HH QRP) Updates

The CY 2026 Final Rule introduces several important revisions to the Home Health Quality Reporting Program (HH QRP), reflecting CMS’s effort to streamline reporting requirements while improving the relevance of quality measures.

Key changes include:

  • Removal of the COVID-19 vaccination reporting measure, signaling a transition away from pandemic-specific reporting requirements.

  • Elimination of four standardized patient assessment data elements (SPADEs), reducing administrative burden on providers.

  • Implementation of a revised HHCAHPS® survey beginning April 2026, designed to modernize patient experience measurement methodologies.

  • Updates to reconsideration and extraordinary circumstance exception (ECE) processes, improving procedural clarity for agencies submitting reporting exceptions.

HealthBridge emphasizes that these changes will require agencies to update internal reporting systems, train clinical and administrative staff, and reassess data validation procedures to ensure continued compliance with HH QRP requirements.

Failure to adapt to revised reporting expectations may result in payment reductions under the Home Health Value-Based Purchasing (HHVBP) program.

Home Health Value-Based Purchasing (HHVBP) Program Enhancements

CMS also finalized significant updates to the Home Health Value-Based Purchasing (HHVBP) Model, which continues to expand financial accountability tied to quality performance outcomes.

Key modifications include:

  • Removal of three HHCAHPS®-based measures, reducing emphasis on certain patient experience domains.

  • Addition of four new performance measures, including:

    • Medicare Spending per Beneficiary – Post-Acute Care (MSPB-PAC)

    • Expanded cost-efficiency indicators tied to utilization patterns

  • Introduction of three new OASIS-based quality measures, focusing on:

    • Home safety education provided to patients and caregivers

    • Medication reconciliation, including over-the-counter (OTC) medications

    • Patient understanding of medication side effects and adherence risks

CMS also adjusted scoring methodologies across multiple domains, placing greater weight on:

  • Clinical outcomes

  • Patient engagement

  • Cost efficiency

  • Preventable utilization reduction

HealthBridge highlights that these changes will require agencies to align QAPI programs, clinical workflows, and documentation systems with outcome-based performance metrics rather than process-based reporting alone.

Conditions of Participation (CoPs) Clarification: Universal OASIS Requirement

A significant clarification in the CY 2026 Final Rule confirms that OASIS assessment requirements apply to all skilled home health patients, regardless of payer source.

This includes patients covered by:

  • Medicare

  • Medicaid

  • Commercial insurance

  • Workers’ compensation

  • Private pay arrangements

This clarification reinforces CMS’s expectation that OASIS is not limited to Medicare beneficiaries but is a universal assessment standard for skilled home health services.

HealthBridge strongly advises agencies to conduct immediate internal audits of:

  • Intake workflows

  • Clinical documentation systems

  • Billing and admission policies

  • Staff training programs

Failure to comply with universal OASIS requirements may result in Condition-level deficiencies during CMS surveys, potentially affecting certification status and reimbursement eligibility.

Provider Enrollment and Program Integrity Expansions

CMS also expanded its program integrity and provider enrollment enforcement authority under the CY 2026 Final Rule.

Key changes include:

  • Expanded authority to deny, revoke, or deactivate Medicare provider enrollment based on compliance concerns.

  • Reduction of reporting timelines for adverse legal or administrative actions from 90 days to 30 days.

  • Expanded criteria for granting retroactive enrollment effective dates, increasing CMS discretion in enrollment determinations.

These provisions reflect CMS’s continued focus on strengthening fraud prevention, ensuring provider accountability, and improving oversight of Medicare-participating entities.

HealthBridge recommends that agencies enhance internal compliance monitoring systems, including:

  • Enrollment tracking systems

  • Credentialing audits

  • Legal disclosure workflows

  • Compliance escalation procedures

HealthBridge Executive Commentary

“While the CY 2026 Final Rule reflects a more moderate financial impact than originally proposed, it introduces meaningful operational and regulatory changes that will affect nearly every aspect of home health agency operations,” stated HealthBridge leadership.

“Agencies must move beyond basic compliance and begin aligning clinical documentation, quality reporting, and financial strategy with the increasingly data-driven expectations of CMS. Those that fail to adapt risk both financial penalties and reduced competitive positioning in a value-based care environment.”

HealthBridge emphasizes that successful adaptation will require integrated improvements across:

  • PDGM financial modeling and reimbursement forecasting

  • HHVBP performance optimization strategies

  • Clinical documentation accuracy and OASIS compliance

  • QAPI program integration and effectiveness

  • Regulatory reporting workflows and audit readiness

  • Provider enrollment oversight and compliance governance

HealthBridge Support for Home Health Agencies

To assist agencies in navigating the CY 2026 regulatory transition, HealthBridge offers comprehensive consulting and operational support services, including:

  • Full-service CMS CoP compliance evaluations

  • OASIS accuracy audits and staff training programs

  • Mock CMS surveys and deficiency remediation support

  • QAPI program development and performance improvement consulting

  • HHVBP optimization strategies and benchmarking analysis

  • Documentation integrity and clinical workflow assessments

  • Provider enrollment and regulatory compliance support

HealthBridge’s goal is to help agencies achieve sustainable compliance while improving clinical outcomes, operational efficiency, and financial performance under evolving CMS regulations.

Conclusion

The CY 2026 CMS Home Health PPS Final Rule introduces a complex combination of payment adjustments, quality reporting revisions, value-based purchasing enhancements, and program integrity expansions. While the overall payment reduction is less severe than initially projected, the cumulative regulatory impact underscores CMS’s continued shift toward outcome-driven, data-intensive home health oversight.

HealthBridge’s analysis concludes that agencies that proactively invest in compliance infrastructure, staff education, documentation accuracy, and QAPI program maturity will be best positioned to succeed under the new regulatory environment.

Agencies that delay preparation risk increased survey exposure, financial penalties, and reduced competitiveness in a rapidly evolving home health landscape.

References

  1. Centers for Medicare & Medicaid Services (CMS). “Home Health Prospective Payment System Final Rule (CY 2026).” Available at: CMS Home Health PPS Rules

  2. Centers for Medicare & Medicaid Services (CMS). “42 CFR Part 484 – Home Health Conditions of Participation.” Available at: Electronic Code of Federal Regulations

  3. Centers for Medicare & Medicaid Services (CMS). “Home Health Value-Based Purchasing (HHVBP) Model.” Available at: CMS Innovation Center HHVBP

  4. Centers for Medicare & Medicaid Services (CMS). “Home Health Quality Reporting Program (HHQRP).” Available at: CMS Quality Reporting Programs

  5. Medicare Payment Advisory Commission (MedPAC). “Report to the Congress: Medicare Payment Policy.” Available at: MedPAC Reports

  6. Agency for Healthcare Research and Quality (AHRQ). “Healthcare Quality Improvement Resources.” Available at: AHRQ Quality Tools

  7. National Association for Home Care & Hospice (NAHC). “Home Health Policy and Regulatory Updates.” Available at: NAHC Official Website